Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis

J. Eckert,P. Renczes-Janetzko,M. Schmidt,A. Magedanz,T. Voigtländer,A. Schmermund
DOI: https://doi.org/10.1007/s00392-018-1369-1
IF: 6.138
2018-09-05
Clinical Research in Cardiology
Abstract:AimsLate in-stent restenosis (ISR) has become increasingly important, in particular due to neo-atherosclerosis. CCTA is a highly sensitive method for detecting coronary plaques. Its diagnostic accuracy regarding ISR is controversial. Stent artifacts can impede image quality, but recent developments in CT-technology may help to overcome some of these problems and allow for improved diagnostic accuracy.MethodsConsecutive patients after previous coronary revascularization who had stable symptoms or signs of possible disease progression were examined using a third-generation dual-source CT scanner. After the scan, patients were followed for clinical events (MACE) over a mean of 399 days. Patients with high-grade stenoses were referred for invasive coronary angiography (ICA), unclear findings were further evaluated either by ICA or functional testing.ResultsOverall, 226 patients were included. A total of 457 stents were evaluated (2.0 ± 1.4 per patient). Mean stent diameter was 2.9 ± 0.45 mm. In 61%, a high-pitch protocol was employed. Mean dose-length product (DLP) of CCTA was 159.2 mGy cm, corresponding to 2.2 mSv using a conversion factor of k = 0.014. Mean amount of contrast agent was 58.3 ± 12.5 ml. In 145 patients (64%), CCTA was negative. In this group, one MACE occurred (acute coronary syndrome) during follow-up in a patient who had also undergone unremarkable ICA. In 23 patients (10%), CCTA detected 28 ISR which were confirmed and treated by ICA (true positive). In 27 patients (12%), ISR was suspected by CCTA but excluded by ICA (false positive), 30 patients (13%) had unclear findings and normal non-invasive tests. No MACE occurred during follow-up in these patients. One patient was misclassified in CCTA as having intermediate and not high-grade ISR who underwent revascularization within 3 months. Eleven patients (5%) were lost to follow-up. During follow-up, eight patients had myocardial infarctions due to five ISRs and three de novo lesions. No patient died. In cases with unclear or false-positive findings, the amount of stents was significantly higher, stents were smaller and patients had a higher BMI.ConclusionIn almost two-thirds of symptomatic patients with previous coronary stent implantation, ISR could be ruled out by CCTA. 10% of patients had definite ISR. The rate of false-negative findings was low (< 1%), whereas the rate of false positive or inconclusive findings was 25%, leading to invasive rule-out of ISR by ICA in 12%. CCTA appears valuable as a tool for safely excluding ISR. It might help to avoid invasive diagnostic procedures. Further analyses are warranted, in particular regarding the influence of stent dimensions and the total amount of stents in a patient.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The problem that this paper attempts to solve is whether coronary CT angiography (CCTA) using third - generation dual - source CT can reliably exclude in - stent restenosis (ISR) in patients after coronary artery stenting. Specifically, the study aims to evaluate the diagnostic accuracy of CCTA in detecting ISR, especially whether it can overcome the problem of impaired image quality due to stent artifacts after the progress of high - resolution CT technology, thereby avoiding unnecessary invasive examinations such as invasive coronary angiography (ICA). ### Research Background - **Importance of ISR**: Late - stage ISR, especially problems caused by new - onset atherosclerosis (NA), is becoming increasingly important. NA refers to the atherosclerotic process that occurs inside the stent months to years after stent implantation, which is different from the atherosclerosis of the native coronary artery, and the latter usually takes decades to appear. - **Advantages and Challenges of CCTA**: CCTA is a highly sensitive method for detecting coronary artery plaques. However, there is controversy regarding its accuracy in the diagnosis of ISR, mainly because stent artifacts may affect image quality. But recent CT technology developments may help overcome these problems and improve diagnostic accuracy. ### Research Objectives - **Evaluate the Feasibility of CCTA**: Study the feasibility and diagnostic accuracy of third - generation dual - source CT in detecting ISR. - **Reduce Unnecessary Invasive Examinations**: Exclude ISR by CCTA to reduce the need for unnecessary ICA and other invasive examinations. - **Analyze Influencing Factors**: Explore the influence of factors such as stent diameter, patient BMI, and the number of stents on the diagnostic accuracy of CCTA. ### Main Conclusions - **High Negative Predictive Value**: CCTA shows a high negative predictive value in excluding ISR, and almost two - thirds of patients can be excluded from ISR by CCTA without further examination. - **Low False - negative Rate**: The false - negative rate is less than 1%, indicating that CCTA is very reliable in excluding ISR. - **False - positive Rate and Indeterminate Results**: The proportion of false - positive rate or indeterminate results is 25%, and these patients need further ICA or functional tests for confirmation. - **Reduce Invasive Examinations**: CCTA can help avoid unnecessary invasive examinations in about two - thirds of patients. ### Future Directions - **Further Research**: More randomized controlled trials are needed to verify the performance of CCTA in patients after stent implantation, especially compared with functional tests, and the influence of stent size and overlap on diagnostic accuracy. In conclusion, this study shows the potential of third - generation dual - source CT in excluding ISR, especially in patients with larger stent diameters, single stents, and normal BMI. CCTA can not only provide reliable diagnostic information but also reduce unnecessary invasive examinations, thereby improving the patient's treatment experience and safety.